Biomarker research in Parkinson's disease
Imaging dopamine transporters in Parkinson's disease
Olfaction as a biomarker in Parkinson's disease
Problems associated with fluid biomarkers for Parkinson's disease
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate
Urate
Autosomal recessive mutations in the development of Parkinson's disease
Biomarkers in Parkinson's disease
Biomarkers in Parkinson's disease
Identification of novel genetic markers and improved treatment options for diabetic kidney disease
Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values
Launch of new cystic fibrosis test announced by industry leader
TB signature may help researchers develop tools to predict development of active disease
Microfluidics-based test for analyzing molecular basis of brain cancer
RNA biomarker assay kit for translational medical researchers
Genome-scale sequencing guides treatment in rare cancer type
Three-biomarker ‘signature’ may help to classify Alzheimer's disease patients
Vascular dysfunction biomarkers are elevated in children with HIV
Circulating proteins predict liver fibrosis in hepatitis C infection
Unique tumor-associated molecule supports the growth and progression of oral carcinoma
High clusterin levels predate evidence of Alzheimer's disease
Cytokine patterns after therapy with Avonex®, Rebif®, Betaferon® and CinnoVexTM in relapsing–remitting multiple sclerosis in Iranian patients
miRNAs as biomarkers for management of patients with colorectal cancer
The need for noninvasive biomarkers for drug safety in neonatal circulation
Acknowledgements